🟢 SAB Biotherapeutics is trading 10% up today

SAB Biotherapeutics is trading at $3.07, up 10.04%, with the move’s specific trigger still unclear.

• Biotech shares were broadly higher, and supplied sector context showed XBI up 2.18%; this may have supported the stock but does not explain its larger gain.
• October 27 coverage identified no clear company-specific catalyst; its highlighted trial/platform discussion did not explain the move.
• The company’s FDA Fast Track news was reported earlier in October, not as a new October 27 announcement.